Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Asset Writedowns and Impairment (2020 - 2025)

Historic Asset Writedowns and Impairment for Marimed (MRMD) over the last 6 years, with Q3 2025 value amounting to -$122000.0.

  • Marimed's Asset Writedowns and Impairment fell 517.24% to -$122000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year increase of 106578.95%. This contributed to the annual value of -$336000.0 for FY2024, which is 38474.58% down from last year.
  • According to the latest figures from Q3 2025, Marimed's Asset Writedowns and Impairment is -$122000.0, which was down 517.24% from $256000.0 recorded in Q2 2025.
  • In the past 5 years, Marimed's Asset Writedowns and Impairment ranged from a high of $3.7 million in Q4 2022 and a low of -$205000.0 during Q4 2024
  • Over the past 5 years, Marimed's median Asset Writedowns and Impairment value was $39000.0 (recorded in 2023), while the average stood at $463529.4.
  • As far as peak fluctuations go, Marimed's Asset Writedowns and Impairment surged by 5272857.14% in 2022, and later plummeted by 40500.0% in 2023.
  • Over the past 5 years, Marimed's Asset Writedowns and Impairment (Quarter) stood at $7000.0 in 2021, then soared by 52728.57% to $3.7 million in 2022, then plummeted by 93.37% to $245000.0 in 2023, then tumbled by 183.67% to -$205000.0 in 2024, then skyrocketed by 40.49% to -$122000.0 in 2025.
  • Its Asset Writedowns and Impairment was -$122000.0 in Q3 2025, compared to $256000.0 in Q2 2025 and $1.4 million in Q1 2025.